Type 2 Diabetes Drug, Metformin, May Reduce Cancer Death Risk In Postmenopausal Women

Type 2 Diabetes Drug, Metformin, May Reduce Cancer Death Risk In Postmenopausal Women

This post was originally published on this site

A widely prescribed drug for type 2 diabetes may also reduce the risk of dying from cancer in older women. A drug commonly prescribed to type 2 diabetes patients may also be able to cut cancer death risk in postmenopausal women, according to new research published in the International Journal of Cancer .

Start the conversation, or Read more at Medical Daily.

 

Comments

 

Add your comments below

Quantcast